Stefano CiattoSummaryCountry: Italy Publications
| Collaborators
|
Detail Information
Publications
Reliability of PSA testing remains unclearStefano Ciatto
BMJ 327:750. 2003
Role of double-contrast barium enema in colorectal cancer screening based on fecal occult bloodStefano Ciatto
Centro per lo Studio e la Prevenzione Oncologica, Scientific Institute of Tuscany Region, Florence, Italy
Tumori 88:95-8. 2002..The present study evaluated the contribution of double-contrast barium enema in detecting neoplastic lesions of the colon in fecal occult-blood-positive subjects with incomplete colonoscopy...
What is the best screening strategy to detect advanced colorectal adenomas? Simulation from ongoing Italian screening experiencesLeonardo Ventura
ISPO Cancer Research and Prevention Institute, Florence, Italy
Tumori 97:547-50. 2011....- Accuracy of prostate volume measurements using transrectal multiplanar three-dimensional sonographyGianluca Giubilei
Department of Urology, University of Florence, Florence, Italy
Int J Urol 12:936-8. 2005.... - Prostate cancer specific mortality in the Florence screening pilot study cohort 1992-1993Stefano Ciatto
Centro per lo Studio e la Prevenzione Oncologica, Viale A Volta 171, 50131 Firenze, Italy
Eur J Cancer 42:1858-62. 2006..99; 95% CI=0.69-1.37). This finding might suggest a screening effect, but might also be ascribed to an healthy screening effect, and cannot be assumed as a reliable evidence of screening efficacy... - Current cancer profiles of the Italian regions: should cancer incidence be monitored at a national level?Stefano Ciatto
Department of Diagnostic Imaging, CSPO, Istituto per la Prevenzione Oncologica, Florence, Italy
Tumori 93:529-31. 2007 - Determining overdiagnosis by screening with DRE/TRUS or PSA (Florence pilot studies, 1991-1994)Stefano Ciatto
Centro per lo Studio e la Prevenzione Oncologica, Viale A Volta 171, 50131 Florence, Italy
Eur J Cancer 41:411-5. 2005..23 in subjects excluded from invitation due to previous cancer or major illness (95%CI=0.8-1.5). A 66% excess incidence rate was observed in the screened subjects over a 9-year period, confirming previous estimates of overdiagnosis... - Reliability of sparing Papanicolaou test conventional reading in cases reported as No Further Review at AutoPap-assisted cytological screening: survey of 30,658 cases with follow-up cytological screeningGrazia Maria Troni
Istituto Scientifico Prevenzione Oncologica CSPO, Florence, Italy
Cancer 111:93-8. 2007..AutoPap-assisted smear reading has been proposed prior to conventional manual reading; the latter may be unnecessary for cases reported as No Further Review (NFR) and would be required for cases reported as Review (REV)... - PSA use and incidence of prostate biopsy in the Tuscany region: is opportunistic screening discounting biopsy in subjects with PSA elevation?Stefano Ciatto
CSPO, Istituto Scientifico per la Prevenzione Oncologica, Florence, Italy
Tumori 94:518-22. 2008..To assess PSA use in the general population and estimate biopsy rate subsequent to opportunistic screening... - Quality control of the autopap screening system employed as a primary screening device: rapid review of smears coded as no further reviewPaolo Bulgaresi
Centro per lo Studio e la Prevenzione Oncologica, Florence, Italy
Tumori 92:276-8. 2006..Rapid review of NFR smears is not recommended as a quality control measure for the negligible yield of high-grade lesions detected... - Interval breast cancers in screening: the effect of mammography review method on classificationStefano Ciatto
Centro per lo Studio e la Prevenzione Oncologica, Viale A Volta 171, 5131, Florence, Italy
Breast 16:646-52. 2007..Due to expected variability, review methods need standardisation to improve screening quality. Our data support blinded review of IC in mammography screening... - Full-field digital versus screen-film mammography: comparative accuracy in concurrent screening cohortsMarco Rosselli Del Turco
Centro per lo Studio e la Prevenzione Oncologica, Viale A Volta 171, 50131 Florence, Italy
AJR Am J Roentgenol 189:860-6. 2007..The purpose of this study was to compare the diagnostic accuracy of digital mammography with that of screen-film mammography in concurrent cohorts participating in the same population-based screening program... - Comparison of two commercial systems for computer-assisted detection (CAD) as an aid to interpreting screening mammogramsStefano Ciatto
Centro per lo Studio e la Prevenzione Oncologica, Firenze, Italy
Radiol Med 107:480-8. 2004..To compare the diagnostic accuracy of two commercial CAD systems (CADx and R2) and their impact as an aid to conventional reading of screening mammograms... - Mammography screening in elderly women: efficacy and cost-effectivenessMarco Zappa
Descriptive and Epidemiological Unit, Center for Study and Prevention of Cancer CSPO, Scientific Institute of Tuscany Region, Via di San Salvi, 12, 50135, Florence, Italy
Crit Rev Oncol Hematol 46:235-9. 2003..Over the age of 74 years, encouraging individualized decisions may be more appropriate and may indicate further screening for those subjects for whom the potential benefit outweighs the potential negative effects... - A feasibility study of the use of the AutoPap screening system as a primary screening and location-guided rescreening deviceMassimo Confortini
Cytology Unit, Centro per lo Studio e la Prevenzione Oncologica, Florence, Italy
Cancer 99:129-34. 2003..Burlington, NC) is an automated device that was designed to screen conventionally prepared cervical smears and, more recently, thin-layer slide preparations. The system has been tested in large clinical trials... - Free to total PSA ratio is not a reliable predictor of prostate biopsy outcomeStefano Ciatto
Centro per lo Studio e la Prevenzione Oncologica, Florence, Italy
Tumori 90:324-7. 2004..The aim of this study was to assess the validity of predictors of prostate biopsy outcome in order to improve their positive predictive value... - Persistent human papilloma virus infection as an indicator of risk of recurrence of high-grade cervical intraepithelial neoplasia treated by the loop electrosurgical excision procedureSilvia Cecchini
Centro per lo Studio e la Prevenzione Oncologica, Florence, Italy
Tumori 90:225-8. 2004..Subjects with negative findings at cytology, colposcopy and HPV testing are at negligible risk of recurrence and might return safely to standard screening protocol... - Cervical intraepithelial neoplasia and higher long term risk of cancerGuglielmo Ronco
BMJ 335:1053-4. 2007 - Ultrasound and mammography for breast cancer screeningNehmat Houssami
JAMA 300:1514-5; author reply 1515. 2008 - [Interval cancers as indicators of performance in screening programmes]Stefano Ciatto
Epidemiol Prev 32:93-8. 2008.... - [Recommendations of a national Italian consensus conference on the opportunity of extending screening service by mammography to 40-49 and 70-74 years of age women]Vito Distante
SOD Chirurgia generale II, AO universitaria, Careggi, Firenze
Epidemiol Prev 31:15-22. 2007.... - Quality control of mammography screening in the Veneto Region. Evaluation of four programs at a local health unit level--analysis of the frequency and diagnostic pattern of interval cancersMarcello Vettorazzi
Registro Tumori Veneto, Padova, Italy
Tumori 92:1-5. 2006..Hospital discharge records-based procedures for interval cancers assessment should be employed routinely in screening programs... - Radiological surveillance of interval breast cancers in screening programmesNehmat Houssami
Screening and Test Evaluation Program STEP, School of Public Health, University of Sydney, New South Wales, Australia
Lancet Oncol 7:259-65. 2006..Standardised radiological surveillance of interval cancers might allow within-programme comparisons and has the potential to guide practice and improve quality... - Detection rates of high-grade prostate cancer during subsequent screening visits. Results of the European Randomized Screening Study for Prostate CancerTheodorus H van der Kwast
Department of Pathology and Urology, Erasmus Medical Center, Rotterdam, The Netherlands, and Centro per la Studio e la Prevenzione Oncologica, University of Florence, Italy
Int J Cancer 118:2538-42. 2006..e. 507/10,000 men). Variations in detection rates among screening centers related among others to biopsy compliance and age range... - Quality assessment of the mammographic screening programme in the Azienda Sanitaria locale Provincia Milano 1 -- analysis of interval cancers and discussion of possible causes of diagnostic errorRossella Burani
Azienda Sanitaria Locale Provincia Milano, Milan
Radiol Med (Torino) 109:260-7. 2005..The present study methodology might be currently applied in screening programmes... - Increasing trends of cervical adenocarcinoma incidence in Central Italy despite Extensive Screening Programme, 1985-2000Carmen B Visioli
Descriptive and Epidemiological Unit, Center for Study and Prevention of Cancer CSPO, Via di San Salvi, 12, 50135 Florence, Italy
Cancer Detect Prev 28:461-4. 2004..The burden of cervical cancers might increase in the future if no specific preventive strategies for adenocarcinoma are implemented... - [Prostate-specific antigen: appropriate and inappropriate use]Stefano Ciatto
U.O. Diagnostica per Immagini, Centro per lo Studio e la Prevenzione Oncologica, Universit, Firenze
Recenti Prog Med 94:95-8. 2003..If opportunistic screening can not be avoided, we should at least avoid too an aggressive diagnostic approach (e.g. random biopsy for borderline [4-10 ng/ml] PSA values)... - Determining the sensitivity of transrectal ultrasonography on a consecutive series of prostate cancers in a clinical and screening settingStefano Ciatto
Tumori 88:281-3. 2002..To evaluate the sensitivity at transrectal ultrasonography (TRUS) for prostate cancer... - Large-scale randomized prostate cancer screening trials: program performances in the European Randomized Screening for Prostate Cancer trial and the Prostate, Lung, Colorectal and Ovary cancer trialHarry J de Koning
Department of Public Health, Erasmus University Rotterdam, PO Box 1738, 3000 DR Rotterdam, The Netherlands
Int J Cancer 97:237-44. 2002..The differences between countries seem to reflect both underlying prostate cancer incidence and screening policy. The trials have the power to show definitive results in 2005-2008...